Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled NO for Postoperative Pulmonary Complications in Recent COVID-19
NCT05721144Phase 2Completed
- Sponsor
- Xijing Hospital
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in postoperative pulmonary complications (PPC), sponsored by Xijing Hospital. Started Feb 2023; status: completed.
02
Drugs
nitric oxide
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT05721144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05721144.